×
About 37,533 results

ALLMedicine™ Positron Emission Tomography Center

Research & Reviews  13,494 results

PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
https://clinicaltrials.gov/ct2/show/NCT02147405

May 20th, 2022 - Immune reconstitution inflammatory syndrome (IRIS) in HIV infection represents a paradoxical, frequently inflammatory, immune response after initiation of antiretroviral (ART) therapy. The immunopathogenesis of IRIS remains elusive partially due t...

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
https://clinicaltrials.gov/ct2/show/NCT03952585

May 20th, 2022 - PRIMARY OBJECTIVES: I. To demonstrate non-inferiority in terms of progression-free survival (PFS) of concurrent reduced-dose radiation therapy (RT) with cisplatin or concurrent reduced-dose radiation therapy with nivolumab to the current standard ...

A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
https://clinicaltrials.gov/ct2/show/NCT03900598

May 20th, 2022 - Non-Hodgkin lymphoma (NHL) represents a diverse set of diseases. Among them diffuse large B-cell lymphoma (DLBCL) represents the most common subtype of NHL, accounting for 30 percent (%) to 40% of all newly diagnosed cases. Mucosa-associated lymph...

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
https://clinicaltrials.gov/ct2/show/NCT04927416

May 20th, 2022 - The study is designed to identify the patients with metastatic radioactive iodine (RAI) non-avid or non-responsive thyroid cancer RAI non-responsive Hurthle cell thyroid cancer (HTC), differentiated thyroid cancer (DTC) and metastatic medullary th...

Vagus Somatosensory Evoked Potentials and Near-infrared Spectroscopy in the Early Diagnosis of Dementia
https://clinicaltrials.gov/ct2/show/NCT02224326

May 20th, 2022 - With the increasing life span of our population, the prevalence of dementia syndromes is increasing. The most frequent cause of dementia is Alzheimer´s disease (AD), and still, it is not curable. Thus, AD is of increasing medical, social and econo...

see more →

Guidelines  17 results

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: P...
https://doi.org/10.1016/j.ejca.2020.01.007
European Journal of Cancer (Oxford, England : 1990); Stratigos AJ, Garbe C et. al.

Mar 3rd, 2020 - Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and ...

European Academy of Neurology guideline on the diagnosis of coma and other disorders of...
https://doi.org/10.1111/ene.14151
European Journal of Neurology; Kondziella D, Bender A et. al.

Feb 25th, 2020 - Patients with acquired brain injury and acute or prolonged disorders of consciousness (DoC) are challenging. Evidence to support diagnostic decisions on coma and other DoC is limited but accumulating. This guideline provides the state-of-the-art e...

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.
https://doi.org/10.1200/JCO.19.02757
Journal of Clinical Oncology : Official Journal of the Am... Trabulsi EJ, Rumble RB et. al.

Jan 16th, 2020 - Provide evidence- and expert-based recommendations for optimal use of imaging in advanced prostate cancer. Due to increases in research and utilization of novel imaging for advanced prostate cancer, this guideline is intended to outline techniques...

European Association of Nuclear Medicine and European Academy of Neurology recommendati...
https://doi.org/10.1111/ene.13728
European Journal of Neurology; Nobili F, Arbizu J et. al.

Jun 23rd, 2018 - Recommendations for using fluorodeoxyglucose positron emission tomography (FDG-PET) to support the diagnosis of dementing neurodegenerative disorders are sparse and poorly structured. Twenty-one questions on diagnostic issues and on semi-automated...

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834038
Annals of Oncology : Official Journal of the European Soc... Younes A, Hilden P et. al.

Apr 6th, 2017 - In recent years, the number of approved and investigational agents that can be safely administered for the treatment of lymphoma patients for a prolonged period of time has substantially increased. Many of these novel agents are evaluated in early...

see more →

Drugs  107 results see all →

Clinicaltrials.gov  813 results

Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
https://clinicaltrials.gov/ct2/show/NCT04235114

May 20th, 2022 - Over-expression of Epidermal Growth Factor Receptor (EGFR) on cells occurs in all aggressive cancers of epithelial origin. Existing tests for monitoring EGFR expression are invasive and not reliable. There needs to be a better way to measure EGFR ...

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
https://clinicaltrials.gov/ct2/show/NCT04133636

May 20th, 2022 - Multiple myeloma is characterized by the production of monoclonal immunoglobulin (Ig) proteins or protein fragments (M proteins) that have lost their function. The main aim of the study is to determine the safety and efficacy of JNJ-68284528 in va...

Effect of Chronic Inflammation on Myocardial Perfusion and Function
https://clinicaltrials.gov/ct2/show/NCT04870827

May 20th, 2022 - Study Description: Heart failure (HF) remains a significant public health burden despite expanding and improving treatment options. Clinical and pre-clinical studies have demonstrated compelling relationships between inflammation, myocardial dysfu...

A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prost...
https://clinicaltrials.gov/ct2/show/NCT04557059

May 20th, 2022 - Prostate cancer is currently the fifth leading cause of cancer deaths among men globally, with 1 million diagnosed per year and mortality burden of over 300,000 deaths. The hypothesis of study is addition of apalutamide to RT+ LHRHa provides super...

Brain Dopamine Function in Human Obesity
https://clinicaltrials.gov/ct2/show/NCT03648892

May 20th, 2022 - Evidence from neuroimaging studies indicates that aberrant functionality in brain regions that support reward processing and habit formation may be related to an individual's eating behavior and obesity propensity. In particular, our previous rese...

see more →

News  524 results

Genomic Testing Challenges Persist
https://www.onclive.com/view/genomic-testing-challenges-persist

May 5th, 2022 - Although molecular biomarkers are becoming increasingly relevant in cancer care, community oncologists confront a plethora of challenges in translating research findings into practice. Structural changes in payment systems and decision-support too...

FDA Clears Diagnostic Test for Early Alzheimer's
https://www.medscape.com/viewarticle/973451

May 4th, 2022 - The US Food and Drug Administration (FDA) has cleared the first in vitro diagnostic to aid in the early detection of Alzheimer's disease (AD). The Lumipulse G β-Amyloid Ratio 1-42/1-40 (Fujirebio Diagnostics) test detects amyloid plaques associate...

Metastatic CRPC: Considerations for Radiotherapy
https://www.onclive.com/view/metastatic-crpc-considerations-for-radiotherapy

May 2nd, 2022 - Transcript: Oliver Sartor, MD: We need to talk a little about history in order to understand how we got to where we are today. I’m going to take you way back to the 1990s, when the first radiopharmaceuticals were FDA [Food and Drug Administration...

Will You Suffer Cardiac Arrest? New Tech May Predict If and When
https://www.medscape.com/viewarticle/972766

Apr 26th, 2022 - COVID-19 fatalities may have captured more attention lately, but heart disease remains the leading cause of death in the U.S. More than 300,000 Americans this year will die of sudden cardiac arrest (also called sudden cardiac death, or SCD), where...

Factors in Selecting Novel AR-Targeted Therapy for Nonmetastatic CRPC
https://www.onclive.com/view/factors-in-selecting-novel-ar-targeted-therapy-for-nonmetastatic-crpc

Apr 17th, 2022 - Transcript: Alicia Morgans, MD, MPH: Matthew, can you go to the next step on that? What are the factors that describe the patient in whom you're going to do that intensification and you've decided that patient now needs to get that additional the...

see more →

Patient Education  58 results see all →